AI Signal Dashboard
Last updated: 05.01 08:54
Top Undervalued
+20.5¢
(No)
Will CVS Health (CVS) beat quarterly earnings? AI analysis: • +20.5¢ undervalued • Live Prediction Market fair value & mispricing alerts.
Undervalued Options Insights:
The current market price has rebounded to 89 cents, indicating strong investor anticipation that CVS...
🔓 Log in to see more
Real-time High Yield Opportunities
View MoreAll
Outcomes
Market
Price
AI Fair
Value
Value
Edge
YesNo
85.5¢
14.5¢
65¢
35¢
0¢
+20.5¢
⚠️ Risk Warning: Live data may lag! Prices can shift instantly due to news or low liquidity. Before trading, use AI Chat for [Live Recalculate], [Check Liquidity], [Trollbox Radar], or review [Fair Value Logic] to verify.
Hedging
CVS
As a major healthcare and retail pharmacy company, CVS's earnings results will directly and significantly impact its own stock price (CVS), often triggering volatile moves of >5% upon release (impact score 4). While it is a component of the S&P 500, a single company's earnings typically have a negligible effect on the broader index (impact score 1). Therefore, this prediction market is primarily useful for hedging idiosyncratic risks associated with CVS stock.
Movers
April 29, 2026 - May 1, 2026, the price of Option_'Yes' surged from 73c to 89c, as market sentiment leaned heavily toward CVS beating expectations approaching the earnings release, with buying pressure driving a rapid recovery.
April 27, 2026 - April 29, 2026, the price of Option_'Yes' experienced violent swings, plunging from 90.5c to 50.5c and then rebounding to 74c, due to severe market divergence regarding CVS's upcoming earnings expectations, or sudden sentiment shifts driven by peer healthcare/pharmacy earnings.
April 24, 2026 - April 27, 2026, the price of Option_'Yes' surged from 50c to 90.5c, as early capital heavily bet on CVS easily beating estimates.